Alternative rapamycin treatment regimens mitigate the impact of rapamycin on glucose homeostasis and the immune system.
about
Finding Ponce de Leon's Pill: Challenges in Screening for Anti-Aging MoleculesInhibition of the Mechanistic Target of Rapamycin (mTOR)-Rapamycin and BeyondIntermittent Administration of Rapamycin Extends the Life Span of Female C57BL/6J MiceThe Mechanistic Target of Rapamycin: The Grand ConducTOR of Metabolism and AgingTemsirolimus Partially Rescues the Hutchinson-Gilford Progeria Cellular PhenotypeLocalised intravascular coagulation complicating venous malformations in children: Associations and therapeutic options.Rapamycin: An InhibiTOR of Aging Emerges From the Soil of Easter Island.Longer lifespan in male mice treated with a weakly estrogenic agonist, an antioxidant, an α-glucosidase inhibitor or a Nrf2-inducer.Differential Regulation of Cardiac Function and Intracardiac Cytokines by Rapamycin in Healthy and Diabetic Rats.Intermittent Fasting Preserves Beta-Cell Mass in Obesity-induced Diabetes via the Autophagy-Lysosome Pathway.Concurrent antitumor and bone-protective effects of everolimus in osteotropic breast cancer.Novel strategies for anti-aging drug discovery.mTOR Signaling in Growth, Metabolism, and Disease.Energetic interventions for healthspan and resiliency with aging.Nutrition and energetics in rodent longevity research.Peptidylprolyl Isomerases as In Vivo Carriers for Drugs That Target Various Intracellular Entities.Restoration of metabolic health by decreased consumption of branched-chain amino acids.Cardioprotective effects of dietary rapamycin on adult female C57BLKS/J-Leprdb mice.Effects of rapamycin on growth hormone receptor knockout mice.Autophagy promotes MSC-mediated vascularization in cutaneous wound healing via regulation of VEGF secretion.mTOR as Regulator of Lifespan, Aging, and Cellular Senescence: A Mini-Review.Intermittent mTOR inhibition reverses kidney aging in old rats.A randomized control trial to establish the feasibility and safety of rapamycin treatment in an older human cohort: Immunological, physical performance, and cognitive effects.Metformin reduces glucose intolerance caused by rapamycin treatment in genetically heterogeneous female mice.Short-term methionine deprivation improves metabolic health via sexually dimorphic, mTORC1-independent mechanisms.β-Cell Autophagy in Diabetes Pathogenesis.Rapamycin rescues BMP mediated midline craniosynostosis phenotype through reduction of mTOR signaling in a mouse modelmTORC Inhibitors as Broad-Spectrum Therapeutics for Age-Related Diseases
P2860
Q26747742-F8D1D8C9-435B-4DEE-8CC9-1A07595B404CQ26751462-BE86B0C3-C180-4601-BCB7-C57D67920B2AQ28275005-DAD86ACF-7BD3-4B4E-9091-FC776C791275Q28276378-EE65A54A-0F5C-4263-96E5-0C6E437D84EFQ28468499-B854DED8-F348-4502-8B7F-B0374D7729A8Q36272665-B64B4997-0639-4D5F-A58A-C10C5AD4F2C1Q37000488-FF2B42CB-AAAE-455B-A078-D74A38AFAA95Q37235568-9402251B-5D56-4C02-983B-C8166D5F591BQ37734346-5919C6C1-B003-436A-B2FA-FD3EDF6CDD7FQ38602310-C21DF177-31D0-425F-AAFF-6B2187A81C98Q38631833-79DF2546-6AEA-4713-8256-1A822AEFAE89Q38659532-2761D946-8A5F-4A3B-AE3C-D37744CFD78AQ38747508-1B4D3529-A1B0-4B5F-A938-EBF8ED0B48CEQ39291992-72D4CF99-FB52-4394-B1A8-9BE8D2DA8E84Q47121848-D12A685E-B6DF-4F66-9FBE-6A5E599FE733Q47134039-917B27BB-7BD2-4157-AB03-9032D4DFEC86Q47266242-D0B84C11-E426-4D8E-BDC6-8A18E2DEEFE4Q47548477-251B3E17-48DF-464F-BC5F-6DE958DAE93CQ48147612-F225B135-B801-456D-ADDE-23FF411217ADQ48204290-EE13435B-DF08-43A5-AE14-361A22E1AA6AQ49486147-252C1E99-6326-4B67-B34C-8CCB5391CEF6Q50114077-FA9354DF-62EF-449D-9AAE-9BA14A0625A5Q50148782-49126EFB-2E34-450A-B507-5048B41AB518Q51734662-1FAC75E7-1427-4809-B7D0-1B191A8E5D88Q52385007-369F4AE5-1EDA-4F88-9614-5D01C8CD22D6Q52607218-85A5FFDB-89F8-4557-999C-2CAEB2756984Q56262145-9FF0B712-672F-4C60-B265-3505A6F56351Q58795101-DBB7CB4F-4C7B-4C91-9F4C-898367714482
P2860
Alternative rapamycin treatment regimens mitigate the impact of rapamycin on glucose homeostasis and the immune system.
description
2015 nî lūn-bûn
@nan
2015 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Alternative rapamycin treatmen ...... ostasis and the immune system.
@ast
Alternative rapamycin treatmen ...... ostasis and the immune system.
@en
Alternative rapamycin treatmen ...... ostasis and the immune system.
@nl
type
label
Alternative rapamycin treatmen ...... ostasis and the immune system.
@ast
Alternative rapamycin treatmen ...... ostasis and the immune system.
@en
Alternative rapamycin treatmen ...... ostasis and the immune system.
@nl
prefLabel
Alternative rapamycin treatmen ...... ostasis and the immune system.
@ast
Alternative rapamycin treatmen ...... ostasis and the immune system.
@en
Alternative rapamycin treatmen ...... ostasis and the immune system.
@nl
P2093
P2860
P356
P1433
P1476
Alternative rapamycin treatmen ...... ostasis and the immune system.
@en
P2093
Cassidy P Pumper
Emma L Baar
Faizan A Syed
Harpreet K Brar
Joshua C Neuman
Michelle E Kimple
Nicole E Cummings
Sebastian I Arriola Apelo
P2860
P356
10.1111/ACEL.12405
P577
2015-10-13T00:00:00Z